95,180 Common Stock of Enlitic, Inc. are subject to a Lock-Up Agreement Ending on 5-MAY-2024.
May 04, 2024
Share
95,180 Common Stock of Enlitic, Inc. are subject to a Lock-Up Agreement Ending on 5-MAY-2024. These Common Stock will be under lockup for 139 days starting from 18-DEC-2023 to 5-MAY-2024.
Details:
4,493,837 shares of common stock (equivalent to 4,493,837 CDIs) classified by ASX as restricted securities and to be held in escrow until February 07, 2024 being 12 months from the date of issue.
95,180 shares of common stock (equivalent to 95,180 CDIs) classified by ASX as restricted securities and to be held in escrow until May 05, 2024 being 12 months from the date of issue.
395,490 shares of common stock (equivalent to 395,490 CDIs) classified by ASX as restricted securities and to be held in escrow until April 18, 2024 being 12 months from the date of issue.
9,471,276 shares of common stock (equivalent to 9,471,276 CDIs) classified by ASX as restricted securities and to be held in escrow until December 19, 2025 being 24 months from the date of commencement of Quotation.
5,235,935 warrants (equivalent to 5,235,935 CDIs upon exercise) exercisable at $1.04555 on or before December 31 2024, classified by ASX as restricted securities and to be held in escrow until December 19, 2025 being 24 months from the date of commencement of Quotation.
55,000 warrants (equivalent to 55,000 CDIs upon exercise) exercisable at $2.84 on or before July 13, 2030, classified by ASX as restricted securities and to be held in escrow until December 19, 2025 being 24 months from the date of commencement of Quotation.
21,551 warrants (equivalent to 21,551 CDIs upon exercise) exercisable at $1.16 on or before October 04, 2028, classified by ASX as restricted securities and to be held in escrow until December 19, 2025 being 24 months from the date of commencement of Quotation.
3,925,401 warrants (equivalent to 3,925,401 CDIs upon exercise) exercisable at $1.0455 on or before December 31, 2024, classified by ASX as restricted securities and to be held in escrow until January 27, 2024 being for 12 months from the date of issue.
10,640,816 options (equivalent to 10,640,816 CDIs upon exercise) with varying exercise prices and expiry dates issued to related parties and promoters under ENL?s employee incentive plan, classified by ASX as restricted securities and to be held in escrow until December 19, 2025 being 24 months from the date of commencement of Quotation.
Enlitic, Inc. is a healthcare information technology (IT) company that uses Artificial Intelligence (AI) in applications to address issues plaguing the delivery of healthcare. Enlitic Curie is the Company's foundational platform that uses AI to unlock the value of the customer's data in real time. ENDEX, the Company's software application powered by the Curie platform, improves every aspect of workflow for radiologists. ENDEX conforms health system data to consistent clinical standards, enables relevant linkage across different care systems, uses AI to create hanging protocol displays, improves image routing and orchestration, and automatically standardizes DICOM descriptions before transmission to PACS. The Company's product consists of standarization, anonymization, and real-world evidence (RWE) database.